Genomic Valley Biotech Closes Trading Window for Q2 FY27 Results

Genomic Valley Biotech Ltd has announced the closure of its trading window effective October 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. This closure is to facilitate the consideration of the un-audited financial results for the quarter and half-year ended September 30, 2026. The trading window will reopen 48 hours after the announcement of these results. During this period, directors, key managerial personnel, designated persons, and their immediate relatives are prohibited from trading in the company's shares and securities. The date for the board meeting to approve these financial results will be communicated separately.